Objectives: To study sex-based differences in the clinical presentation in relation to age and type of acute coronary syndrome (ACS) in patients under 80 years of age. Methods: The study includes 1,744 consecutive patients with the full spectrum of ACS (ST elevation myocardial infarction (MI), non-ST elevation MI, and unstable angina of high- and low-risk types) admitted to the coronary care unit in a university hospital. Results: The women were older than the men and were as likely to present with ST elevation MI. They had lower rates of prior MI and prior coronary artery bypass surgery than men but similar rates of percutaneous coronary interventions. Further, women were less likely to have a short delay before admission to hospital and they were attended to less rapidly in the emergency department. The prevalence of risk factors, prior cardiovascular disease and ongoing treatment with cardiovascular drugs were strongly associated with less severe type of ACS with no significant sex interaction. Presentation with non-ST elevation MI was significantly associated with older age while the opposite was true for unstable low-risk angina. ECG signs of acute ischemia were not associated with age. Significant interactions between age and sex were observed for the prevalence of treatment with diuretics as well as hypotension at presentation, both more prevalent among women than men below 65 years of age. Conclusions: Women are struck by ACS at a higher age than men, are less likely to present early for hospital care, and at younger age women are more likely to present with hypotension. There is a striking difference in risk factors and previous history depending on type of ACS in both sexes.

Keywords:
Acute coronary syndromes, Age, Sex interaction
1.
Falk E: Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983;50:127–134.
2.
Davies MJ: The pathophysiology of acute coronary syndromes. Heart 2000;83:361–366.
3.
Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group: Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1,000 patients. Lancet 1994;343:311–322.
4.
White HD, Van de Werf FJ: Thrombolysis for acute myocardial infarction. Circulation 1998;97:1632–1646.
5.
TIMI III Investigators: Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 1994;89:1545–1556.
6.
Armstrong PW, Fu Y, Chang WC, Topol EJ, Granger CB, Betriu A, Van de Werf F, Lee KL, Califf RM: Acute coronary syndromes in the GUSTO-IIb trial: Prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. Circulation 1998;98:1860–1868.
7.
Fox KA, Goodman SG, Klein W, Brieger D, Steg PG, Dabbous O, Avezum A: Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002;23:1177–1189.
8.
Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, Aylward P, Topol EJ, Califf RM: Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med 1999;341:226–232.
9.
WHO: Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i–xii, 1–253.
10.
Diderholm E, Andren B, Frostfeldt G, Genberg M, Jernberg T, Lagerqvist B, Lindahl B, Venge P, Wallentin L: The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: The FRISC II invasive troponin T electrocardiogram substudy. Am Heart J 2002;143:760–767.
11.
Hamm CW, Bertrand M, Braunwald E: Acute coronary syndrome without ST elevation: Implementation of new guidelines. Lancet 2001;358:1533–1538.
12.
Herlitz J, Karlson BW, Karlsson T, Svensson L, Bjorn Kalin EZ: A description of the characteristics and outcome of patients hospitalized for acute chest pain in relation to whether they were admitted to the coronary care unit or not in the thrombolytic era. Int J Cardiol 2002;82:279–287.
13.
Karlson BW, Herlitz J, Pettersson P, Ekvall HE, Hjalmarson A: Patients admitted to the emergency room with symptoms indicative of acute myocardial infarction. J Intern Med 1991;230:251–258.
14.
GISSI Investigators: Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI). Lancet 1986;i:397–402.
15.
The GUSTO investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673–682.
16.
Lagerqvist B, Safstrom K, Stahle E, Wallentin L, Swahn E: Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators. J Am Coll Cardiol 2001;38:41–48.
17.
Hochman JS, McCabe CH, Stone PH, Becker RC, Cannon CP, DeFeo-Fraulini T, Thompson B, Steingart R, Knatterud G, Braunwald E: Outcome and profile of women and men presenting with acute coronary syndromes: A report from TIMI IIIB. TIMI Investigators. Thrombolysis in myocardial infarction. J Am Coll Cardiol 1997;30:141–148.
18.
Karlson BW, Hartford M, Herlitz J: Treatment of patients with acute myocardial infarction in relation to gender. Cardiology 1996;87:230–234.
19.
Lunet N, Barros H: Gender differences in the treatment of hypertension: A community based study in Porto. Rev Port Cardiol 2002;21:7–19.
20.
Mahon NG, Codd MB, McKenna CJ, O’Rorke C, McCann HA, Sugrue DD: Characteristics and outcomes in patients with acute myocardial infarction with ST segment depression on initial electrocardiogram. Am Heart J 2000;139:311–319.
21.
Klungel OH, de Boer A, Paes AH, Seidell JC, Bakker A: Sex differences in the pharmacological treatment of hypertension: A review of population-based studies. J Hypertens 1997;15:591–600.
22.
Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP: The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;286:1195–1200.
23.
Kannel WB, D’Agostino RB, Cobb JL: Effect of weight on cardiovascular disease. Am J Clin Nutr 1996;63:419S–422S.
24.
Sclavo M: Cardiovascular risk factors and prevention in women: Similarities and differences. Ital Heart J 2001;2:125–141.
25.
Lissner L, Johansson SE, Qvist J, Rossner S, Wolk A: Social mapping of the obesity epidemic in Sweden. Int J Obes Relat Metab Disord 2000;24:801–805.
26.
Gibler WB, Armstrong PW, Ohman EM, Weaver WD, Stebbins AL, Gore JM, Newby LK, Califf RM, Topol EJ: Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience. Ann Emerg Med 2002;39:123–130.
27.
Rosenfeld AG: Women’s risk of decision delay in acute myocardial infarction: Implications for research and practice. AACN Clin Issues 2001;12:29–39.
28.
Goldberg RJ, Steg PG, Sadiq I, Granger CB, Jackson EA, Budaj A, Brieger D, Avezum A, Goodman S: Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry). Am J Cardiol 2002;89:791–796.
29.
Bosetti C, Negri E, Tavani A, Santoro L, La Vecchia C: Smoking and acute myocardial infarction among women and men: A case-control study in Italy. Prev Med 1999;29:343–348.
30.
Prescott E, Scharling H, Osler M, Schnohr P: Importance of light smoking and inhalation habits on risk of myocardial infarction and all- cause mortality. A 22-year follow-up of 12,149 men and women in The Copenhagen City Heart Study. J Epidemiol Community Health 2002;56:702–706.
31.
The PURSUIT Trial Investigators: Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998;339:436–443.
32.
PRISM-PLUS Study Investigators: Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338:1488–1497.
33.
Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM: Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999;341:217–225.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.